IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 394 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $307,268 | +13.7% | 6,774 | +2.8% | 0.00% | 0.0% |
Q2 2023 | $270,347 | +11.5% | 6,589 | -2.9% | 0.00% | 0.0% |
Q1 2023 | $242,424 | +92782.8% | 6,783 | -1.6% | 0.00% | 0.0% |
Q4 2022 | $261 | -99.9% | 6,893 | +1.8% | 0.00% | 0.0% |
Q3 2022 | $300,000 | +17.6% | 6,772 | -1.8% | 0.00% | 0.0% |
Q2 2022 | $255,000 | -33.1% | 6,897 | -33.0% | 0.00% | 0.0% |
Q1 2022 | $381,000 | +10.1% | 10,293 | -9.4% | 0.00% | 0.0% |
Q4 2021 | $346,000 | +15.3% | 11,356 | +26.9% | 0.00% | 0.0% |
Q3 2021 | $300,000 | +1.7% | 8,949 | +21.0% | 0.00% | 0.0% |
Q2 2021 | $295,000 | -6.6% | 7,396 | +5.3% | 0.00% | 0.0% |
Q1 2021 | $316,000 | +28.5% | 7,027 | +68.3% | 0.00% | 0.0% |
Q2 2020 | $246,000 | -6.5% | 4,175 | -24.9% | 0.00% | 0.0% |
Q1 2020 | $263,000 | -19.6% | 5,559 | +2.7% | 0.00% | 0.0% |
Q4 2019 | $327,000 | -6.6% | 5,414 | -7.3% | 0.00% | 0.0% |
Q3 2019 | $350,000 | -6.7% | 5,841 | +0.3% | 0.00% | 0.0% |
Q2 2019 | $375,000 | +49.4% | 5,824 | +88.7% | 0.00% | 0.0% |
Q1 2019 | $251,000 | – | 3,087 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |